A Peek Into The Market Before The Trading Starts

Pre-open movers US stock futures are higher this morning, after data showed strong Q1 growth in the euro zone. Gold and silver prices also surged, while the US dollar dropped versus major currencies. Futures on the Dow Jones Industrial Average gained 14 points to 12,686.00 and futures on the S&P 500 stock index rose 2.20 points to 1,349.70. Nasdaq 100 futures climbed 1.75 points to 2,408.75. A Peek Into Global Markets Most Asian markets ended higher, with Japan's Nikkei Stock Average dipping 0.70%, Australia's S&P/ASX 200 moving up 0.23% and China's Shanghai Composite gaining 0.95%. Hong Kong's Hang Seng Index rose 0.88% and India's Sensex surged 1.35%. European markets were higher today. The STOXX Europe 600 Index has gained 0.07%, London's FTSE 100 Index moved up 0.78%. Broker Recommendation Analysts at Goldman Sachs upgraded Dean Foods Company DF from “neutral” to “buy.” The target price for DF has been raised from $10 to $19. DF shares gained 2.85% to $12.63 in pre-market trading. Breaking news

• Wal-Mart Stores Inc WMT agreed to buy a minority stake in the holding company of Chinese eCommerce company Yihaodian. To read the full news, click here.
• Yum! Brands YUM, the owner of the KFC and Taco Bell fast-food chains, said it will take Little Sheep, the operator of Chinese hotpot restaurants, private in a deal valued at $862 million. To read the full news, click here.
• Mylan Inc. MYL today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Risperidone Orally Disintegrating Tablets, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the generic version of Ortho-McNeil's Risperdal® M-Tab®, a treatment for schizophrenia. To read the full news, click here.
• Tianyin Pharmaceutical TPI today announced that TPI has received the China's SFDA's approval for its anti-diabetic drug Gliclazide Tablets (80 mg formulation). To read the full news, click here.

Read more from Benzinga's Markets.